Digital

A team of scientists have broken records with their new AI which has found a novel drug candidate for liver cancer in only 30 days

A new AI has been developed to deliver medicines at a faster rate and lower cost

Becton, Dickinson and Company has revealed its new-generation robotic track system

A recently developed AI model has been shown to predict ten-year incidences with a similar level of success to the current standard of care.

Anumana, an AI-driven health technology firm, has signed a multi year deal with Pfizer in order to develop an AI electrocardiogram (AI-ECG) for the early detection of cardiac amyloidosis.

Connected health firm Withings has unveiled its new in-home biomarker analysis platform U-Scan. It is hoped the device will utilise the “wealth of health information in daily urine.”

Eli Lilly lost billions in stock following tweets from a fake but verified account on twitter

Elon Musk's Neuralink announces that human trials are planned for its brain chip in 2023

Novo Nordisk's connected pens are now compatible with Abbott's FreeStyle LibreLink app

Brainomix – the AI-powered MedTech solutions company – and Bridge Biotherapeutics, a clinical-stage biotechnology company focused on developing novel drugs for cancer, fibrosis, and inflammation, have announced a new partnership.

These resources offer a blueprint for future development of digital endpoints

In the last decade, AI has taken the field of neurology by storm. It has particularly revolutionised the way that Parkinson’s is diagnosed, researched, and managed. Lina Adams explores the technological advances that are underway as researchers aim to understood more about Parkinson’s pathology.